Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The granulin precursor protein (progranulin) is a secreted glycoprotein that plays diverse roles in cell growth, wound healing, inflammation, lysosomal function, and neuronal survival. It is the precursor for granulins, a family of smaller peptides generated by proteolytic cleavage. Mutations or deficiencies in progranulin are associated with frontotemporal lobar degeneration (FTLD), neuronal ceroid lipofuscinosis and Lupus nephritis. It acts both extracellularly via signal transduction pathways and intracellularly via transcriptional modulation. It's involved in normal lysosome function, and deficiency impairs cellular waste processing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulin Precursor Protein (PGRN).